2023
DOI: 10.1016/j.ejmech.2022.114915
|View full text |Cite
|
Sign up to set email alerts
|

Natural quinazolinones: From a treasure house to promising anticancer leads

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
16
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 20 publications
(16 citation statements)
references
References 188 publications
0
16
0
Order By: Relevance
“…3). [89][90][91][92] For example, the sulfonamide 3m could be transformed into antidiabetic sulfonylurea derivative 3m-urea in 98% yield and 98% ee, which demonstrated the scalability of this powerful protocol for the synthesis of bioactive compounds.…”
Section: Synthetic Applicationsmentioning
confidence: 96%
“…3). [89][90][91][92] For example, the sulfonamide 3m could be transformed into antidiabetic sulfonylurea derivative 3m-urea in 98% yield and 98% ee, which demonstrated the scalability of this powerful protocol for the synthesis of bioactive compounds.…”
Section: Synthetic Applicationsmentioning
confidence: 96%
“…Alkaloids are a diverse group of naturally occurring compounds that contain ring structures and mostly basic nitrogen atoms. [1] Due to their wide pharmacological activity, alkaloids are compelling compounds for the development of drugs and have great potential for the treatment of a wide array of pathologies. These promising alkaloids include luotonin, camptothecin, tryptanthrin, and rutaecarpine.…”
Section: Introductionmentioning
confidence: 99%
“…Quinazolinones have a wide range of biological activities and pharmacological properties [11], including anti-inflammatory [10], bactericidal [12], anti-tuberculosis [13], anti-diabetic [14], anti-HIV [15], and anti-cancer [16] effects. In particular, natural quinazolinones and quinazolinone derivatives have shown great potential in anticancer research, and several quinazolinone derivatives have been used in clinical cancer treatments, such as idelalisib, nolatrexed, and raltitrexed dihydrochloride [17]; however, no studies on the anti-cancer properties of MITC quinazolinone derivatives have been reported.…”
Section: Introductionmentioning
confidence: 99%